206 related articles for article (PubMed ID: 38066929)
1. Amyloid consults do not have to be vexing.
D'Souza A
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):407-412. PubMed ID: 38066929
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment.
Zanwar S; Gertz MA; Muchtar E
J Natl Compr Canc Netw; 2023 Jan; 21(1):83-90. PubMed ID: 36630897
[TBL] [Abstract][Full Text] [Related]
3. Management of the elderly patient with AL amyloidosis.
Nuvolone M; Milani P; Palladini G; Merlini G
Eur J Intern Med; 2018 Dec; 58():48-56. PubMed ID: 29801808
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
5. [Light chain amyloidosis].
Hegenbart U; Aus dem Siepen F; Schönland S
Inn Med (Heidelb); 2023 Sep; 64(9):842-847. PubMed ID: 37540260
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
7. [AL amyloidosis, from diagnosis to treatment].
Villesuzanne C; Jaccard A; Nicol M
Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
[TBL] [Abstract][Full Text] [Related]
8. Fundamentals of Light Chain Cardiac Amyloidosis: A Focused Review.
Latif A; Lateef N; Razzaq F; Kapoor V; Ahsan MJ; Ashfaq M; Iftikhar A; Anwer F; Holmberg M; William P
Cardiovasc Hematol Disord Drug Targets; 2020; 20(4):274-283. PubMed ID: 33256586
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
[TBL] [Abstract][Full Text] [Related]
10. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.
Angel-Korman A; Jaberi A; Sanchorawala V; Havasi A
Amyloid; 2020 Mar; 27(1):17-24. PubMed ID: 31595786
[No Abstract] [Full Text] [Related]
11. Amyloidosis of the Heart and Kidney.
Adrogue HE
Methodist Debakey Cardiovasc J; 2022; 18(4):27-33. PubMed ID: 36132587
[TBL] [Abstract][Full Text] [Related]
12. [AL Amyloidosis].
Ueda M
Brain Nerve; 2024 May; 76(5):583-587. PubMed ID: 38741500
[TBL] [Abstract][Full Text] [Related]
13. Management of AL amyloidosis in 2020.
Palladini G; Milani P; Merlini G
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):363-371. PubMed ID: 33275753
[TBL] [Abstract][Full Text] [Related]
14. [Local and systemic light chain amyloidosis in patients with rheumatic diseases].
Veelken K; Hegenbart U; Schönland SO; Blank N
Z Rheumatol; 2020 Sep; 79(7):660-668. PubMed ID: 32767072
[TBL] [Abstract][Full Text] [Related]
15. The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
Cohen OC; Sharpley F; Gilbertson JA; Wechalekar AD; Sachchithanantham S; Mahmood S; Whelan CJ; Martinez-Naharro A; Fontana M; Lachmann HJ; Hawkins PN; Gillmore JD
Eur J Haematol; 2020 Sep; 105(3):352-356. PubMed ID: 32495369
[TBL] [Abstract][Full Text] [Related]
16. Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M; Nasr L; Khalid F; Allam S; Bouferraa Y; Batool S; Tayyeb M; Adroja S; Mammadii M; Anwer F; Raza S; Chaulagain CP
Oncotarget; 2023 Apr; 14():384-394. PubMed ID: 37185672
[TBL] [Abstract][Full Text] [Related]
17. Systemic immunoglobulin light-chain amyloidosis.
Comenzo RL
Clin Lymphoma Myeloma; 2006 Nov; 7(3):182-5. PubMed ID: 17229332
[TBL] [Abstract][Full Text] [Related]
18. Individualized Approach to Management of Light Chain Amyloidosis.
Palladini G; Milani P
J Natl Compr Canc Netw; 2023 Jan; 21(1):91-98. PubMed ID: 36634608
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021.
Hasib Sidiqi M; Gertz MA
Blood Cancer J; 2021 May; 11(5):90. PubMed ID: 33993188
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias.
Kourelis TV; Kumar SK; Go RS; Kapoor P; Kyle RA; Buadi FK; Gertz MA; Lacy MQ; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Zeldenrust SR; Rajkumar SV; Dispenzieri A
Am J Hematol; 2014 Nov; 89(11):1051-4. PubMed ID: 25111004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
